FDA Drug recall D-1139-2023
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississaug…
- FDA Drug
- Class III
- terminated
- Published 2023-09-06
On 2023-09-06 the FDA classified a Class III recall of Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississaug… by Contract Pharmaceuticals Canada, citing defective Container: slow leakage under the cap.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1139-2023 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2023-08-23 |
| Published | 2023-09-06 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Contract Pharmaceuticals Canada |
| Distribution | US |
Product
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60
Reason
Defective Container: slow leakage under the cap
Identifiers
| code_info | Lot # 118920, exp. January 2024. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1139-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.